Inspectors Find Illegal Marketing by Herbal Drugmaker Quanjian

TRENDING: U.S. Tightens Export Controls to Cover Subsidiaries of Blacklisted Firms; DeepSeek Unveils New Model With Sparse Attention, Slashes API Costs; Tech Brief (Sept. 30): U.S. Widens Export Blacklist

LATEST: Tech Brief (Sept. 30): U.S. Widens Export Blacklist; U.S. Tightens Export Controls to Cover Subsidiaries of Blacklisted Firms; DeepSeek Unveils New Model With Sparse Attention, Slashes API Costs; Tech Brief (Sept. 29): Meituan’s Food-Delivery Platform Keeta Launches in Dubai; Chinese Chipmaker Moore Threads Gets Fast Track Approval to $1.1 Billion IPO; Chinese Drone Maker XAG Files for Hong Kong IPO After First Annual Profit; GPT Weekly: Nvidia to Invest $100 Billion in OpenAI; Tech Brief (Sept. 26): Trump Approves TikTok Deal; Xiaomi Ups the Stakes in Premium Market With iPhone-Style 17 Series; Yangtze Memory’s Parent Restructures to Pave Way for IPO Amid Sanctions Pressures; Tech Brief (Sept. 25): Alibaba Launches AI Models; Alibaba Bets Big on ‘AI + Cloud’ With New Models, Nvidia Deal; GlobalFoundries Boosts U.S. Investment, Adds China Fabs to Meet Auto Chip Demand; Tech Brief (Sept. 24): Mercedes-Benz, ByteDance Partner on In-Car AI; Tech Brief (Sept. 23): Nvidia Plans $100 Billion Investment in OpenAI for AI Data Centers; Tech Brief (Sept. 22): Trump Says Murdoch Family May Be Involved in TikTok Deal; GPT Weekly: CoreWeave Secures $6.3 Billion Nvidia Order; Huawei Unveils Three-Year AI Chip Roadmap as Nvidia Faces Setbacks in China; Tencent Cloud Shuns Price War in Intensifying AI Race; China’s Regulator Ramps Up Push to Curb Food Delivery Subsidy War

By Han Wei / Dec 29, 2018 02:40 AM / Business & Tech

Photo: VCG

An initial investigation of herbal medicines and health foods producer Quanjian Group Co. Ltd. found that the company committed violations by exaggerating the benefits of its products, the state broadcaster China Central Television reported Friday.

A formal investigation has been initiated against Quanjian by the Tianjin city market regulator on allegations of violating market competition law, said the report.

Tianjin-based Quanjian has been under public scrutiny since Dingxiangyuan, an online health news portal, published an article Tuesday reporting that the company exaggerated the benefits of its products, which contributed to the 2015 death of a 4-year-old with cancer. Tianjin authorities sent inspectors to the company after the report went viral.

Quanjian also faces questions on whether it was involved in pyramid sales, which are banned in China. An official on the inspection team said the probe is still underway, according to the CCTV report.

Share this article

Open WeChat and scan the QR code